In fact, apart from CLU, also CEBPB and D seem to play a role in PC proliferation, as interleukin-6 (IL-6) treatment increases the expression of CEBP-D family member, inducing IL-6/STAT3-dependent growth arrest on prostate cancer cells in vitro [80]. This evidence concerns the gene CLU and prostate cancer.